Skip to main content

Advertisement

Table 4 HIV treatment and other determinants of abnormal lipid profile in HIV-infected individuals in Yaounde, Cameroon

From: First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study

Outcome variables Explanatory variables Adjusted OR
(95% CI)
P
TC ≥ 200 (mg/dl) Antiretroviral therapy 1.82 (1.06-3.12) 0.02
  Sex (Women vs. Men) 0.83 (0.48-1.43) 0.49
  Age > 40 years 1.27 (0.74-2.17) 0.39
  BMI > 25 kg/m2 1.05 (0.59-1.86) 0.87
  Active tuberculosis 0.49 (0.28-0.86) 0.01
  CD4 count ≤ 200/mm3 2.56 (0.34-20.00) 0.36
LDL-c ≥ 130 (md/dl) Antiretroviral therapy 2.99 (1.74-5.15) < 0.0001
  Sex (Women vs. Men) 1.06 (0.61-1.82) 0.84
  Age > 40 years 1.13 (0.66-1.94) 0.65
  BMI > 25 kg/m2 1.87 (1.07-3.27) 0.02
  Active tuberculosis 0.54 (0.31-0.95) 0.03
  CD4 count ≤ 200/mm3 1.92 (0.24-15.74) 0.54
TC/HDL-c ratio ≥ 5 Antiretroviral therapy 1.73 (1.04-2.89) 0.03
  Sex (Women vs. Men) 1.88 (1.11-3.20) 0.02
  Age > 40 years 1.49 (0.89-2.50) 0.20
  BMI > 25 kg/m2 0.68 (0.40-1.17) 0.16
  Active tuberculosis 1.12 (0.67-1.89) 0.68
  CD4 count ≤ 200/mm3 1.78 (0.22-14.43) 0.59
  1. BMI, body mass index; OR, odds ratio; CI, confidence interval; LDL-c, LDL cholesterol;
  2. TC, total cholesterol; HDL-c, HDL cholesterol